185 related articles for article (PubMed ID: 22104205)
1. Future perspectives for the development of chemotherapy for advanced gastric cancer: Japanese and global status.
Higuchi K; Tanabe S; Azuma M; Sasaki T; Ishido K; Koizumi W
Pathobiology; 2011; 78(6):334-42. PubMed ID: 22104205
[TBL] [Abstract][Full Text] [Related]
2. Perspectives for personalization in chemotherapy of advanced gastric cancer.
Boku N
Discov Med; 2010 Feb; 9(45):84-9. PubMed ID: 20193632
[TBL] [Abstract][Full Text] [Related]
3. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973
[TBL] [Abstract][Full Text] [Related]
4. [Current status and future perspectives on chemotherapy in patients with gastric cancer: can the clinical data from Japan lead to a standard international therapy?].
Kim R; Yoshida K; Toge T
Nihon Geka Gakkai Zasshi; 2001 Oct; 102(10):770-7. PubMed ID: 11681004
[TBL] [Abstract][Full Text] [Related]
5. Geographic differences in approach to advanced gastric cancer: Is there a standard approach?
Kim R; Tan A; Choi M; El-Rayes BF
Crit Rev Oncol Hematol; 2013 Nov; 88(2):416-26. PubMed ID: 23764501
[TBL] [Abstract][Full Text] [Related]
6. [New interesting chemotherapeutic regimens in advanced gastric cancer].
Taguchi T
Gan To Kagaku Ryoho; 1991 May; 18(6):945-51. PubMed ID: 1709348
[TBL] [Abstract][Full Text] [Related]
7. Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer.
Farhat FS; Kattan J; Ghosn MG
Expert Rev Anticancer Ther; 2010 Apr; 10(4):541-8. PubMed ID: 20397919
[TBL] [Abstract][Full Text] [Related]
8. Molecular-targeted therapy for chemotherapy-refractory gastric cancer: a case report and literature review.
Kuo HY; Yeh KH
Anticancer Res; 2014 Jul; 34(7):3695-9. PubMed ID: 24982389
[TBL] [Abstract][Full Text] [Related]
9. What is the reference cytotoxic regimen for advanced gastric cancer: standard versus optimal therapy?
Sohal DP; Sun W
Expert Rev Anticancer Ther; 2011 Dec; 11(12):1843-50. PubMed ID: 22117152
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920
[TBL] [Abstract][Full Text] [Related]
11. Management of advanced gastric cancer.
Price TJ; Shapiro JD; Segelov E; Karapetis CS; Pavlakis N; Van Cutsem E; Shah MA; Kang YK; Tebbutt NC
Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):199-208; quiz 209. PubMed ID: 22375525
[TBL] [Abstract][Full Text] [Related]
12. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
[TBL] [Abstract][Full Text] [Related]
13. [Present state and prospects of adjuvant chemotherapy for gastric cancer].
Hori T; Ozawa R; Hanayama H; Yamashita H; Kaibe N; Matsumoto T; Oshima T; Takemura M; Kikuchi S; Sasako M
Gan To Kagaku Ryoho; 2011 Sep; 38(9):1390-5. PubMed ID: 21918333
[TBL] [Abstract][Full Text] [Related]
14. Challenges in first line chemotherapy and targeted therapy in advanced gastric cancer.
Garrido M; Fonseca PJ; Vieitez JM; Frunza M; Lacave AJ
Expert Rev Anticancer Ther; 2014 Aug; 14(8):887-900. PubMed ID: 24953238
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer.
Cheng AL; Yeh KH; Lin JT; Hsu C; Liu MY
Anticancer Res; 1998; 18(2B):1267-72. PubMed ID: 9615799
[TBL] [Abstract][Full Text] [Related]
16. [Standard chemotherapy for gastrointestinal malignancies based on evidence].
Sasaki T; Maeda Y; Kobayashi T; Okamoto R; Omuro Y; Takada N
Gan To Kagaku Ryoho; 2000 Feb; 27(2):166-76. PubMed ID: 10700886
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for advanced gastric cancer: future perspective in Japan.
Shitara K
Gastric Cancer; 2017 Mar; 20(Suppl 1):102-110. PubMed ID: 27699493
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
19. [Recent advances in chemotherapy for advanced gastric cancer: from the standpoint of survival advantages].
Ohtsu A; Yoshida S; Miyata Y; Shimada Y
Gan To Kagaku Ryoho; 1995 Mar; 22(4):444-50. PubMed ID: 7887636
[TBL] [Abstract][Full Text] [Related]
20. Current questions for the treatment of advanced gastric cancer.
Cervantes A; Roda D; Tarazona N; Roselló S; Pérez-Fidalgo JA
Cancer Treat Rev; 2013 Feb; 39(1):60-7. PubMed ID: 23102520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
